Gregory S Downs (Gregory Downs)

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 11

Top Topics

Breast Cancer Risk

Acute Myeloid Leukemia

Top Venues

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

Nature communications

Journal of clinical pathology

This page only lists publications with an associated author ORCID identifier.

Publications

Peter J B Sabatini, Josh Bridgers, Shujun Huang, Gregory S Downs, Tong Zhang, Clare Sheen, Nicole Park, Robert Kridel, Marco A Marra, Christian Steidl, David W Scott, Aly Karsan
Multisite clinical cross-validation and variant interpretation of a next generation sequencing panel for lymphoid cancer prognostication. Journal of clinical pathology (2024)
Andrew Seto, Gregory S Downs, Olivia King, Shabnam Salehi-Rad, Ana Baptista, Kayu Chin, Sylvie Grenier, Bevoline Nwachukwu, Anne Tierens, Mark D Minden, Adam C Smith, José-Mario Capo-Chichi
Genomic Characterization of Partial Tandem Duplication Involving the KMT2A Gene in Adult Acute Myeloid Leukemia. Cancers 16 (9) (2024)
Andrew Seto, Gregory S Downs, Olivia King, Shabnam Salehi-Rad, Ana Baptista, Kayu Chin, Sylvie Grenier, Bevoline Nwachukwu, Anne Tierens, Mark D Minden, Adam C Smith, José-Mario Capo-Chichi
Genomic Characterization of Partial Tandem Duplication Involving the KMT2A Gene in Adult Acute Myeloid Leukemia. Cancers 16 (9) (2024)
Ainhoa Madariaga, Swati Garg, Nairi Tchrakian, Neesha C Dhani, Waldo Jimenez, Stephen Welch, Helen MacKay, Josee-Lyne Ethier, Lucy Gilbert, Xuan Li, Angela Rodriguez, Lucy Chan, Valerie Bowering, Blaise Clarke, Tong Zhang, Ian King, Gregory S Downs, Tracy L Stockley, Lisa Wang, Smitha Udagani, Amit M Oza, Stephanie Lheureux
Clinical outcome and biomarker assessments of a multi-centre phase II trial assessing niraparib with or without dostarlimab in recurrent endometrial carcinoma. Nature communications 14 (1) (2023)
Nasim Mavaddat, Lorenzo Ficorella, Tim Carver, Andrew J Lee, Alex P Cunningham, Michael Lush, Joe G Dennis, Marc Tischkowitz, Kate Downes, Donglei Hu, Eric Hahnen, Rita K Schmutzler, Tracy L Stockley, Gregory S Downs, Tong Zhang, Anna M Chiarelli, Stig Egil Bojesen, Cong Liu, Wendy K Chung, Monica Pardo, Lidia Feliubadaló, Judith Balmaña, Jacques Simard, Antonis C Antoniou, Douglas F Easton
Incorporating Alternative Polygenic Risk Scores into the BOADICEA Breast Cancer Risk Prediction Model. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 32 (3) (2023)
Nasim Mavaddat, Lorenzo Ficorella, Tim Carver, Andrew J Lee, Alex P Cunningham, Michael Lush, Joe G Dennis, Marc Tischkowitz, Kate Downes, Donglei Hu, Eric Hahnen, Rita K Schmutzler, Tracy L Stockley, Gregory S Downs, Tong Zhang, Anna M Chiarelli, Stig Egil Bojesen, Cong Liu, Wendy K Chung, Monica Pardo, Lidia Feliubadaló, Judith Balmaña, Jacques Simard, Antonis C Antoniou, Douglas F Easton
Incorporating alternative Polygenic Risk Scores into the BOADICEA breast cancer risk prediction model. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2023)
Nasim Mavaddat, Lorenzo Ficorella, Tim Carver, Andrew J Lee, Alex P Cunningham, Michael Lush, Joe G Dennis, Marc Tischkowitz, Kate Downes, Donglei Hu, Eric Hahnen, Rita K Schmutzler, Tracy L Stockley, Gregory S Downs, Tong Zhang, Anna M Chiarelli, Stig Egil Bojesen, Cong Liu, Wendy K Chung, Monica Pardo, Lidia Feliubadaló, Judith Balmaña, Jacques Simard, Antonis C Antoniou, Douglas F Easton
Incorporating Alternative Polygenic Risk Scores into the BOADICEA Breast Cancer Risk Prediction Model. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 32 (3) (2023)
Ainhoa Madariaga, Swati Garg, Nairi Tchrakian, Neesha C Dhani, Waldo Jimenez, Stephen Welch, Helen MacKay, Josee-Lyne Ethier, Lucy Gilbert, Xuan Li, Angela Rodriguez, Lucy Chan, Valerie Bowering, Blaise Clarke, Tong Zhang, Ian King, Gregory S Downs, Tracy L Stockley, Lisa Wang, Smitha Udagani, Amit M Oza, Stephanie Lheureux
Clinical outcome and biomarker assessments of a multi-centre phase II trial assessing niraparib with or without dostarlimab in recurrent endometrial carcinoma. Nature communications 14 (1) (2023)
Nasim Mavaddat, Lorenzo Ficorella, Tim Carver, Andrew J Lee, Alex P Cunningham, Michael Lush, Joe G Dennis, Marc Tischkowitz, Kate Downes, Donglei Hu, Eric Hahnen, Rita K Schmutzler, Tracy L Stockley, Gregory S Downs, Tong Zhang, Anna M Chiarelli, Stig Egil Bojesen, Cong Liu, Wendy K Chung, Monica Pardo, Lidia Feliubadaló, Judith Balmaña, Jacques Simard, Antonis C Antoniou, Douglas F Easton
Incorporating Alternative Polygenic Risk Scores into the BOADICEA Breast Cancer Risk Prediction Model. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 32 (3) (2023)
Ainhoa Madariaga, Swati Garg, Nairi Tchrakian, Neesha C Dhani, Waldo Jimenez, Stephen Welch, Helen MacKay, Josee-Lyne Ethier, Lucy Gilbert, Xuan Li, Angela Rodriguez, Lucy Chan, Valerie Bowering, Blaise Clarke, Tong Zhang, Ian King, Gregory S Downs, Tracy L Stockley, Lisa Wang, Smitha Udagani, Amit M Oza, Stephanie Lheureux
Clinical outcome and biomarker assessments of a multi-centre phase II trial assessing niraparib with or without dostarlimab in recurrent endometrial carcinoma. Nature communications 14 (1) (2023)
Nasim Mavaddat, Lorenzo Ficorella, Tim Carver, Andrew J Lee, Alex P Cunningham, Michael Lush, Joe G Dennis, Marc Tischkowitz, Kate Downes, Donglei Hu, Eric Hahnen, Rita K Schmutzler, Tracy L Stockley, Gregory S Downs, Tong Zhang, Anna M Chiarelli, Stig Egil Bojesen, Cong Liu, Wendy K Chung, Monica Pardo, Lidia Feliubadaló, Judith Balmaña, Jacques Simard, Antonis C Antoniou, Douglas F Easton
Incorporating alternative Polygenic Risk Scores into the BOADICEA breast cancer risk prediction model. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2023)